These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20586561)

  • 21. Antibiotic resistance: a clinician's perspective.
    Hawkes CA
    Mil Med; 2000 Jul; 165(7 Suppl 2):43-5. PubMed ID: 10920638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ECCMID 2016: addressing the burden of recurrent Clostridium difficile infections.
    Eckmann C; Lyon S
    Future Microbiol; 2016 Oct; 11():1217-1221. PubMed ID: 27679929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and Antibiotic-Susceptibility Profiling of Infectious Bacterial Agents: A Review of Current and Future Trends.
    Maugeri G; Lychko I; Sobral R; Roque ACA
    Biotechnol J; 2019 Jan; 14(1):e1700750. PubMed ID: 30024110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial Stewardship Programs: Principles and Practice.
    Cunha CB
    Med Clin North Am; 2018 Sep; 102(5):797-803. PubMed ID: 30126571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial stewardship programs and surgery: What is our role?
    Manuel Vázquez A; Balibrea JM; Ramia JM
    Cir Esp (Engl Ed); 2019 Apr; 97(4):187-189. PubMed ID: 30217335
    [No Abstract]   [Full Text] [Related]  

  • 26. Surveillance and monitoring of antimicrobial resistance and antibiotic consumption in humans and animals.
    Silley P; Simjee S; Schwarz S
    Rev Sci Tech; 2012 Apr; 31(1):105-20. PubMed ID: 22849271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella species.
    Georgi E; Schacht E; Scholz HC; Splettstoesser WD
    J Antimicrob Chemother; 2012 Oct; 67(10):2429-33. PubMed ID: 22763567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of CLSI Breakpoint Changes on Microbiology Laboratories and Antimicrobial Stewardship Programs.
    Heil EL; Johnson JK
    J Clin Microbiol; 2016 Apr; 54(4):840-4. PubMed ID: 26791363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals.
    MacKenzie FM; Gould IM; Bruce J; Mollison J; Monnet DL; Krcmery V; Cookson B; van der Meer JW
    J Hosp Infect; 2007 Jun; 65 Suppl 2():73-81. PubMed ID: 17540246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Searching High and Low: Call for a Joint European Society for Paediatric Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing Survey on Dosage of Antibacterial Agents in Children-Part One.
    Aguilera-Alonso D; Cantón R; Giske CG; Kahlmeter G; Kohns Vasconcelos M; Papan C; Turnidge J
    Pediatr Infect Dis J; 2022 Apr; 41(4):e182-e185. PubMed ID: 35153290
    [No Abstract]   [Full Text] [Related]  

  • 31. Microbial disease trends and acquired antibiotic resistance: Part 1.
    Molinari JA
    Compend Contin Educ Dent; 1997 Feb; 18(2):106-8. PubMed ID: 9452530
    [No Abstract]   [Full Text] [Related]  

  • 32. Toward an integrated program for patient care in pediatric infections.
    Schaad UB
    Pediatr Infect Dis J; 1997 Mar; 16(3 Suppl):S34-8. PubMed ID: 9076833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the Clinical Microbiology Laboratory in Antimicrobial Stewardship.
    Bouza E; Muñoz P; Burillo A
    Med Clin North Am; 2018 Sep; 102(5):883-898. PubMed ID: 30126578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial surfaces: A need for stewardship?
    Cassidy SS; Sanders DJ; Wade J; Parkin IP; Carmalt CJ; Smith AM; Allan E
    PLoS Pathog; 2020 Oct; 16(10):e1008880. PubMed ID: 33057433
    [No Abstract]   [Full Text] [Related]  

  • 35. The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study.
    Temime L; Hejblum G; Setbon M; Valleron AJ
    Epidemiol Infect; 2008 Mar; 136(3):289-98. PubMed ID: 17767792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress on the development of rapid methods for antimicrobial susceptibility testing.
    Pulido MR; García-Quintanilla M; Martín-Peña R; Cisneros JM; McConnell MJ
    J Antimicrob Chemother; 2013 Dec; 68(12):2710-7. PubMed ID: 23818283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tackling antibiotic resistance in India.
    Wattal C; Goel N
    Expert Rev Anti Infect Ther; 2014 Dec; 12(12):1427-40. PubMed ID: 25353717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infectious diseases as a clinical specialty in Germany and Europe].
    Kern WV; Fätkenheuer G; Tacconelli E; Ullmann A
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(7):493-9. PubMed ID: 26593764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic resistance--what we have to do now?].
    Hryniewicz W
    Pol Merkur Lekarski; 2011 May; 30(179):305-9. PubMed ID: 21675128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility testing and patterns of resistance at a tertiary care center.
    Akhter J; Qutub MO; Qadri SM
    Saudi Med J; 2001 Jul; 22(7):569-76. PubMed ID: 11479635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.